Xeris Biopharma Holdings, Inc.

XERS·NasdaqGS
Compare
10.46−0.02 (−0.19%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.48
Open10.47
Day range10.3310.55
52-week range5.2511.33
Off day high−0.85%
Off 52-week high−7.68%
Volume1.33M
Avg. volume (3M)2.19M
Market cap1.91B
EPS (TTM)-0.1000
Forward P/E28.27
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding182.32M
Short interest—
Earnings dateAug 6, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
XERS AMLX SUPN NBIX AQST AMPH
Market cap 1.91B 3.45B 2.49B 14.37B 603.71M 1.14B
P/E (TTM) — — — 20.6 — 15.9
Forward P/E 28.3 -23.9 9.6 11.8 -8.4 8.4
Price/book -186.8 12.8 2.4 3.9 -10.7 1.5
Dividend yield — — — — — —
1-year change +28.82% +93.66% −13.02% +3.02% −30.09% +12.15%
Today −0.19% −2.35% +0.33% −0.75% +0.63% +0.53%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All XERS news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.